×
App Icon
The Standard e-Paper
Kenya’s Boldest Voice
★★★★ - on Play Store
Download App

Two thirds of Coronavirus patients improve after Gilead drug

FILE PHOTO: A Gilead Sciences Inc. office is shown in Foster City, California, US May 1, 2018. [Reuters]

More than two-thirds of severely ill Covid-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc. (GILD.O), according to new data based on patient observation.

Get Full Access for Ksh299/Week.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in